Logo image of ORN

ORION GROUP HOLDINGS INC (ORN) Stock Fundamental Analysis

USA - NYSE:ORN - US68628V3087 - Common Stock

8.693 USD
+0.03 (+0.38%)
Last: 9/29/2025, 10:50:02 AM
Fundamental Rating

4

ORN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 53 industry peers in the Construction & Engineering industry. ORN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ORN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ORN was profitable.
In the past year ORN had a positive cash flow from operations.
ORN had negative earnings in 4 of the past 5 years.
In the past 5 years ORN always reported a positive cash flow from operatings.
ORN Yearly Net Income VS EBIT VS OCF VS FCFORN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.41%, ORN is in line with its industry, outperforming 49.06% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.82%, ORN is in line with its industry, outperforming 47.17% of the companies in the same industry.
With a Return On Invested Capital value of 6.34%, ORN perfoms like the industry average, outperforming 52.83% of the companies in the same industry.
Industry RankSector Rank
ROA 2.41%
ROE 6.82%
ROIC 6.34%
ROA(3y)-2.7%
ROA(5y)-1.48%
ROE(3y)-8.32%
ROE(5y)-4.43%
ROIC(3y)N/A
ROIC(5y)N/A
ORN Yearly ROA, ROE, ROICORN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 1.25%, ORN is doing worse than 62.26% of the companies in the same industry.
ORN's Operating Margin of 2.20% is on the low side compared to the rest of the industry. ORN is outperformed by 62.26% of its industry peers.
ORN's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 12.68%, ORN perfoms like the industry average, outperforming 41.51% of the companies in the same industry.
In the last couple of years the Gross Margin of ORN has grown nicely.
Industry RankSector Rank
OM 2.2%
PM (TTM) 1.25%
GM 12.68%
OM growth 3YN/A
OM growth 5Y80.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.86%
GM growth 5Y4.85%
ORN Yearly Profit, Operating, Gross MarginsORN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

5

2. Health

2.1 Basic Checks

ORN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ORN has more shares outstanding than it did 1 year ago.
ORN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ORN has been reduced compared to a year ago.
ORN Yearly Shares OutstandingORN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ORN Yearly Total Debt VS Total AssetsORN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.82 indicates that ORN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ORN has a Altman-Z score of 2.82. This is comparable to the rest of the industry: ORN outperforms 50.94% of its industry peers.
ORN has a debt to FCF ratio of 2.88. This is a good value and a sign of high solvency as ORN would need 2.88 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.88, ORN is doing good in the industry, outperforming 67.92% of the companies in the same industry.
ORN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.26, ORN is doing good in the industry, outperforming 71.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 2.88
Altman-Z 2.82
ROIC/WACC0.54
WACC11.81%
ORN Yearly LT Debt VS Equity VS FCFORN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ORN has a Current Ratio of 1.38. This is a normal value and indicates that ORN is financially healthy and should not expect problems in meeting its short term obligations.
ORN has a better Current ratio (1.38) than 64.15% of its industry peers.
ORN has a Quick Ratio of 1.37. This is a normal value and indicates that ORN is financially healthy and should not expect problems in meeting its short term obligations.
ORN has a Quick ratio of 1.37. This is in the better half of the industry: ORN outperforms 69.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.37
ORN Yearly Current Assets VS Current LiabilitesORN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 322.22% over the past year.
The Revenue has grown by 15.85% in the past year. This is quite good.
ORN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.37% yearly.
EPS 1Y (TTM)322.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%143.75%
Revenue 1Y (TTM)15.85%
Revenue growth 3Y9.81%
Revenue growth 5Y2.37%
Sales Q2Q%6.83%

3.2 Future

ORN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 148.81% yearly.
ORN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.37% yearly.
EPS Next Y314.1%
EPS Next 2Y200.66%
EPS Next 3Y148.81%
EPS Next 5YN/A
Revenue Next Year-3.14%
Revenue Next 2Y2.06%
Revenue Next 3Y6.11%
Revenue Next 5Y2.37%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ORN Yearly Revenue VS EstimatesORN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ORN Yearly EPS VS EstimatesORN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.73, which indicates a rather expensive current valuation of ORN.
81.13% of the companies in the same industry are more expensive than ORN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.54. ORN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 24.04, ORN is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ORN indicates a somewhat cheap valuation: ORN is cheaper than 66.04% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, ORN is valued at the same level.
Industry RankSector Rank
PE 21.73
Fwd PE 24.04
ORN Price Earnings VS Forward Price EarningsORN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ORN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ORN is cheaper than 90.57% of the companies in the same industry.
ORN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ORN is cheaper than 73.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.13
EV/EBITDA 8.83
ORN Per share dataORN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ORN's earnings are expected to grow with 148.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y200.66%
EPS Next 3Y148.81%

0

5. Dividend

5.1 Amount

No dividends for ORN!.
Industry RankSector Rank
Dividend Yield N/A

ORION GROUP HOLDINGS INC

NYSE:ORN (9/29/2025, 10:50:02 AM)

8.693

+0.03 (+0.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners80.28%
Inst Owner Change4.06%
Ins Owners5.29%
Ins Owner Change0.33%
Market Cap345.46M
Analysts80
Price Target10.91 (25.5%)
Short Float %3.9%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.03%
Min Revenue beat(2)2.49%
Max Revenue beat(2)9.57%
Revenue beat(4)2
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-20.96%
Max Revenue beat(4)9.57%
Revenue beat(8)3
Avg Revenue beat(8)-4.01%
Revenue beat(12)6
Avg Revenue beat(12)-1.88%
Revenue beat(16)10
Avg Revenue beat(16)2.07%
PT rev (1m)-3.82%
PT rev (3m)-3.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.74%
EPS NY rev (1m)2.5%
EPS NY rev (3m)9.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.87%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 21.73
Fwd PE 24.04
P/S 0.41
P/FCF 19.13
P/OCF 8.26
P/B 2.26
P/tB 2.26
EV/EBITDA 8.83
EPS(TTM)0.4
EY4.6%
EPS(NY)0.36
Fwd EY4.16%
FCF(TTM)0.45
FCFY5.23%
OCF(TTM)1.05
OCFY12.11%
SpS21.07
BVpS3.85
TBVpS3.85
PEG (NY)0.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.41%
ROE 6.82%
ROCE 8.02%
ROIC 6.34%
ROICexc 6.39%
ROICexgc 6.39%
OM 2.2%
PM (TTM) 1.25%
GM 12.68%
FCFM 2.16%
ROA(3y)-2.7%
ROA(5y)-1.48%
ROE(3y)-8.32%
ROE(5y)-4.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y90.92%
ROICexc growth 3YN/A
ROICexc growth 5Y92.87%
OM growth 3YN/A
OM growth 5Y80.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.86%
GM growth 5Y4.85%
F-Score8
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 2.88
Debt/EBITDA 0.89
Cap/Depr 90.52%
Cap/Sales 2.84%
Interest Coverage 1.37
Cash Conversion 93.6%
Profit Quality 172.93%
Current Ratio 1.38
Quick Ratio 1.37
Altman-Z 2.82
F-Score8
WACC11.81%
ROIC/WACC0.54
Cap/Depr(3y)53.27%
Cap/Depr(5y)56.11%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)322.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%143.75%
EPS Next Y314.1%
EPS Next 2Y200.66%
EPS Next 3Y148.81%
EPS Next 5YN/A
Revenue 1Y (TTM)15.85%
Revenue growth 3Y9.81%
Revenue growth 5Y2.37%
Sales Q2Q%6.83%
Revenue Next Year-3.14%
Revenue Next 2Y2.06%
Revenue Next 3Y6.11%
Revenue Next 5Y2.37%
EBIT growth 1Y1267.28%
EBIT growth 3YN/A
EBIT growth 5Y84.81%
EBIT Next Year265.23%
EBIT Next 3Y71.82%
EBIT Next 5YN/A
FCF growth 1Y172.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y396.86%
OCF growth 3Y465.76%
OCF growth 5YN/A